| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2023 ( Subtotal = -$747,631 ) |
| 2023 | 2020 | ICAGEN-T, INC. | 2090 E INNOVATION PARK DR | ORO VALLEY | AZ | 85755-1965 | PIMA | USA | R01DK119656 | High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes | 001 | 2 | NIH | 3/13/2023 | -$625,517 |
| 2023 | 2019 | ICAGEN-T, INC. | 2090 E INNOVATION PARK DR | ORO VALLEY | AZ | 85755-1965 | PIMA | USA | R01DK119656 | High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes | 000 | 1 | NIH | 3/13/2023 | -$122,114 |
|
 | Issue Date FY: 2021 ( Subtotal = $0 ) |
| 2021 | 2020 | ICAGEN-T, INC. | 2090 E INNOVATION PARK DR | ORO VALLEY | AZ | 85755-1965 | PIMA | USA | R01DK119656 | High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes | 000 | 2 | NIH | 2/4/2021 | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = $625,517 ) |
| 2020 | 2020 | ICAGEN-T, INC. | 2090 E INNOVATION PARK DR | ORO VALLEY | AZ | 85755-1965 | PIMA | USA | R01DK119656 | High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes | 000 | 2 | NIH | 1/24/2020 | $562,964 |
| 2020 | 2020 | ICAGEN-T, INC. | 2090 E INNOVATION PARK DR | ORO VALLEY | AZ | 85755-1965 | PIMA | USA | R01DK119656 | High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes | 001 | 2 | NIH | 2/10/2020 | $62,553 |
|
 | Issue Date FY: 2019 ( Subtotal = $632,099 ) |
| 2019 | 2019 | ICAGEN-T, INC. | 2090 E INNOVATION PARK DR | ORO VALLEY | AZ | 85755-1965 | PIMA | USA | R01DK119656 | High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes | 000 | 1 | NIH | 2/27/2019 | $632,099 |
|
|